Market news

Detailed price information for Intercure Ltd (INCR-Q) from The Globe and Mail including charting and trades.

NEW YORK and HERZLIYA, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) anno...

InterCure (INCR) said Tuesday it has regained compliance with Nasdaq's minimum bid price listing rul

Detailed price information for Intercure Ltd (INCR-Q) from The Globe and Mail including charting and trades.

InterCure Ltd. (NASDAQ:INCR) finalized a NIS 230 million, or approximately $77 million, settlement with Israeli authorities covering indirect damages from the October 7, 2023 attacks and subsequent war. The more relevant figure for investors is approximately $43 million. The $77 million represents aggregate compensation rather than a new cash payment. InterCure Ltd. (NASDAQ:INCR) previously received […]

Detailed price information for Intercure Ltd (INCR-Q) from The Globe and Mail including charting and trades.

Company intends to accelerate the rehabilitation of Canndoc’s flagship Nir Oz facility, supporting a return to full production and the Company’s expansion in the growing German medical cannabis market NEW YORK and HERZLIYA, Israel, Aug. 24, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”), today announced that it has reached a final settlement with the Israeli Tax Authorities and Compensation Fund regarding the Company’s claim for indirect damage

Strategic Action Aimed at Regaining Compliance with Nasdaq’s Minimum Bid Price Requirement and Protecting Continued Listing Status NEW YORK and HERTZLIYA, ISRAEL, Aug. 19, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (the “Company” or “InterCure”) (Nasdaq: INCR), today announced that it intends to effect a one-for-five reverse split (the "Reverse Share Split") of the Company’s ordinary shares, no par value per share, (the "Ordinary Shares"). The Ordinary Shares will continue to trade on the Nasdaq Gl